Safety of belimumab in adult patients with systemic lupus erythematosus: Results of a large integrated analysis of controlled clinical trial data

OBJECTIVES: Systemic lupus erythematosus (SLE) is a chronic, autoimmune disease that affects multiple organ systems. Belimumab, a targeted human monoclonal antibody, binds to and inhibits soluble B-lymphocyte stimulator. The safety and efficacy of belimumab has consistently been demonstrated in mult...

Descripción completa

Detalles Bibliográficos
Autores principales: Wallace, Daniel J, Atsumi, Tatsuya, Daniels, Mark, Hammer, Anne, Meizlik, Paige, Quasny, Holly, Schwarting, Andreas, Zhang, Fengchun, Roth, David A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Papers
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679798/
https://www.ncbi.nlm.nih.gov/pubmed/36206400
http://dx.doi.org/10.1177/09612033221131183

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9679798/
https://www.ncbi.nlm.nih.gov/pubmed/36206400
http://dx.doi.org/10.1177/09612033221131183

Ejemplares similares